Our Solexa sequencing data demonstrated a significantly elevated serum miR-146a-5p expression in NSCLC patients (n = 36), with the concurrence of reduced TRAF6 levels at mRNA and protein levels (Figures 5D–H). The gene discussed is TRAF6; the disease is non-small cell lung carcinoma.